Flavio Milana

Inaugural Robotic Pancreas and Liver Surgery Course for IRCAD North America will take place on April21-24. This will be an excellent course for all surgical oncologists, liver Transplant surgeons and Hepatopancreatobiliary surgeons. Course is directed by Prof John Martinie in NC

Talks 🗣️, friends 🤗 and squirrels 🐿️ at the International Society of Liver Surgeons Congress in Toronto 🍁

New operations & concepts of oncological radicality, led parenchymal-sparing surgery (scaffold-sparing surgery) to its highest expression. All of that now on @AnnalsofSurgery @HUNIMED @HumanitasMilano @IHPBA @AHPBA @EAHPBA @APHPBA @SSATNews @IASGO_1988 @IrcadFrance @SocSurgOnc

Pleased to announce the release of another scaffold sparing solution for boosting one stage removal of multiple bilobar colorectal liver metastases: SLICED LIVER HEPATECTOMY @HumanitasMilano @HUNIMED @IHPBA @AHPBA @EAHPBA @APHPBA @IASGO_1988 @SSATNews @SocSurgOnc @Aicep4

From the June Issue of @AnnSurgOncol: Long-Term Outcomes According to #SurgicalMargin in Mass-Forming #Cholangiocarcinoma : The Role of R1vasc @Fla_doc @TorzilliGuido @simonefamularo rdcu.be/eqpcG @vitor__moutinho @SyedAAhmad5

June Issue: Long-Term Outcomes According to #SurgicalMargin in Mass-Forming #Cholangiocarcinoma : The Role of R1vasc @Fla_doc @TorzilliGuido @simonefamularo rdcu.be/eqpcG @vitor__moutinho @SyedAAhmad5

Pleased to announce the online first publication on @AnnSurgOncol of the latest release about R1vasc Liver Surgery: pure R1vasc works also for MFCCC. @HumanitasMilano @HUNIMED @IHPBA @EAHPBA @AHPBA @APHPBA @Aicep4 @SSATNews @IASGO_1988

It is my pleasure to share our latest release on Surgery disclosing a predictive model for communicating veins presence: key factor for liver tunnel, and upper trasversal hepatectomies. @IHPBA @EAHPBA @AHPBA @APHPBA @SSATNews @IASGO_1988 @HumanitasMilano @HUNIMED @Aicep4

Excited to share our latest publication on leukocyte scores in iCCA patients undergoing liver resection! 🔗 Check it out here: doi.org/10.1097/js9.00… @HumanitasMilano @UniAvogadro @TorzilliGuido @matteo_donadon @analleo @MichelaPolid @simonefamularo

@SSATNews #FoundationReception the heroes of the closure @DDWMeeting @Fla_doc @ARuzzenente @YoKawaguchiUT @CDTzeng @TsengJennifer @a_burez

Cholangiocarcinoma on chip! Dr. Michela Polidoro (@MichelaPolid) from @HumanitasMilano shared her fascinating research on developing a microfluid model that mimics the in-vivo-like CCA microenvironment #AMMF2024 #LiverTwitter

24-28/6/2024: 1st ESSU Masterclass. 3D-cast planning, 3D-model printing, hands-on IOUS, live US-guided liver surgery. humanitasedu.it\essu.it @HUNIMED @HumanitasMilano @IHPBA @EAHPBA @APHPBA2023 @AHPBA @SSATNews @IASGO_1988 @Aicep4 @SIC_chirurgia

Day 2 morning session of #EASL #LiverCancerSummit 2024 focusing on really important topics on AI and liq biomarkers for liver cancer. Great talks from @Caldera60373705 @maximeronot @ArndtVogel @Fla_doc!

@Fla_doc discusses combining blood inflammatory scores predicts survival and reflects the tumor niche in intrahepatic cholangiocarcinoma at #LiverCancerSummit 2024! - The combination of blood inflammatory indexes resulted in the identification of two survival-risk profiles - Adding CA19.9 identified a high-risk subgroup with an increased risk of recurrence - A subgroup analysis on tumour microenvironment reflects the systemic results. Future perspectives: - A validation cohort is needed to confirm the results - Tumour microenvironment dynamics need to be better investigated (e.g. characterising T cell phenotype: activation/exhaustion) - These results and dynamics could help in the selection of patients who may benefit from dedicated follow-up and/or immunochemotherapy protocols.

@Fla_doc elegantly presented data on iCCA: Combining blood inflammatory indexes resulted in the identification of two survival-risk profiles. Adding Ca19.9 identified a high-risk subgroup with an increased risk of recurrence @HumanitasMilano @analleo @TorzilliGuido @EASLedu

Delighted to announce that I've been granted the Umberto Veronesi Foundation fellowship! 🧬🔬 Gratitude to @Fondaz_Veronesi for this exceptional opportunity!

🆘 CCA is a deadly cancer 🧬 preclinical research is key! 🆕 CCA-on-a-chip model just published in ⁦@JHEP_Reports⁩ ⁦@EASLnews⁩ 🙏🏻support ⁦⁦@AIRC_it⁩ ⁦@HUNIMED⁩ ⁦@polimi⁩ ⁦@RasponiMarco⁩ ⁦⁦@MichelaPolid⁩ jhep-reports.eu/action/showPdf…

@JHepatology Congrats @F__Colapietro !!!

🆕Article in press❕ Incidence and predictors of #hepatocellularcarcinoma in patients with #autoimmunehepatitis Read it here👉bit.ly/46JfrlY #LiverTwitter

SAVE THE DATE SSAT Italy Chapter Webinar - Updates in Liver Surgery - October 27, 2023 Register here: ssat.com/webinar/